- Home
- ELV vs XNCR Comparison
ELV vs XNCR Comparison
Compare ELV & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELV
- XNCR
- Stock Information
- Founded
- ELV 1944
- XNCR 1997
- Country
- ELV United States
- XNCR United States
- Employees
- ELV 104200
- XNCR N/A
- Industry
- ELV Medical Specialities
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- ELV Health Care
- XNCR Health Care
- Exchange
- ELV Nasdaq
- XNCR Nasdaq
- Market Cap
- ELV 78.4B
- XNCR 579.3M
- IPO Year
- ELV N/A
- XNCR 2013
- Fundamental
- Price
- ELV $339.02
- XNCR $8.80
- Analyst Decision
- ELV Strong Buy
- XNCR Buy
- Analyst Count
- ELV 14
- XNCR 7
- Target Price
- ELV $509.07
- XNCR $27.50
- AVG Volume (30 Days)
- ELV 1.8M
- XNCR 788.7K
- Earning Date
- ELV 07-17-2025
- XNCR 08-04-2025
- Dividend Yield
- ELV 2.01%
- XNCR N/A
- EPS Growth
- ELV N/A
- XNCR N/A
- EPS
- ELV 25.60
- XNCR N/A
- Revenue
- ELV $183,124,000,000.00
- XNCR $127,228,000.00
- Revenue This Year
- ELV $11.19
- XNCR N/A
- Revenue Next Year
- ELV $7.29
- XNCR $28.84
- P/E Ratio
- ELV $13.31
- XNCR N/A
- Revenue Growth
- ELV 6.63
- XNCR N/A
- 52 Week Low
- ELV $337.61
- XNCR $7.16
- 52 Week High
- ELV $567.26
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- ELV 30.96
- XNCR 54.21
- Support Level
- ELV $343.72
- XNCR $7.93
- Resistance Level
- ELV $348.50
- XNCR $9.48
- Average True Range (ATR)
- ELV 9.20
- XNCR 0.52
- MACD
- ELV -2.91
- XNCR 0.11
- Stochastic Oscillator
- ELV 2.24
- XNCR 73.21
About ELV Elevance Health Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.